MMR, autism and inflammatory bowel disease: Responding to patient concerns using an evidence-based framework

Medical Journal of Australia

Volumn 175, Issue 3, 2001, Pages 127-128

  MacIntyre, R C ^a   McIntyre, P B ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

AUTISM; CLINICAL TRIAL; CROHN DISEASE; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; ENTERITIS; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; HUMAN; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; NONHUMAN; ULCERATIVE COLITIS; VIROLOGY;

EID: 0035816919     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2001.tb143058.x     Document Type: Editorial

References (16)

1. Evidence of persistent measles virus infection in Crohn's disease
2. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children
3. Time trends in autism and in MMR immunization coverage in California
4. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: A time trend analysis
5. The epidemiology of autism: A review
6. Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association
7. Autism and associated medical disorders in a French epidemological survey
8. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up
9. Immunohistochemical analysis of the distribution of measles related antigen in the intestinal mucosa in inflammatory bowel disease
10. Further evidence of the absence of measles virus genome sequence in full thickness intestinal specimens from patients with Crohn's disease
11. User's guides to the medical literature. IV. How to use in an article about harm. Evidence-Based Medicine Working Group
12. Sir Austin Bradford Hill: Medical Statistics and the quantitative approach to prevention of disease
13. Measles-mumps-rubella vaccine and autistics spectrum disorder: Report from the New Challeneges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12-13, 2000
14. Statement on the use of MMR vaccine